- Home
- AMRN vs FT Comparison
AMRN vs FT Comparison
Compare AMRN & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMRN | FT |
|---|---|---|
| Founded | 1989 | 1988 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 202.6M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | FT |
|---|---|---|
| Price | $13.78 | $7.91 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 81.1K | 63.0K |
| Earning Date | 10-29-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $5.97 |
| 52 Week High | $20.90 | $7.23 |
Technical Indicators
Market Signals| Indicator | AMRN | FT |
|---|---|---|
| Relative Strength Index (RSI) | 31.56 | 45.43 |
| Support Level | $13.64 | $7.80 |
| Resistance Level | $14.49 | $7.91 |
| Average True Range (ATR) | 0.73 | 0.10 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 5.26 | 33.33 |
Price Performance
Historical ComparisonAbout AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.